Life Technologies' Q3 Revenues Rise 8 Percent on Record SOLiD 4 Sales

The company's CE and next-generation sequencing business saw strong results, while its PCR business suffered from difficult year-ago comparison figures, it said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories